Table 1.

Effect of Lut/ZnO NPs on serum lipid parameters.

Groups	Parameters
	TC (mg/dl)	TGs (mg/dl)	TGt (mg/g)	HDL-C (mg/dl)	FFA (mg/g)
Control	132.5 ± 24a,b,c	80.4 ± 4.5a,b,c	6.2 ± 0.14a,b,c	58.6 ± 2a,b,c	1.32 ± 0.06a,b,c
Lut/ZnO NPs	130.7 ± 1.7b,c,d	72.1 ± 3.2b,c,d	6.1 ± 0.04b,c,d	62.5 ± 1.7b,c,d	1.62 ± 0.7b,c,d
HFD	233.5 ± 3.8a,d,c	140.3 ± 1.7a,d,c	9.1 ± 0.06a,d,c	35.3 ± 1.6a,d,c	4.13 ± 0.03a,d,c
HFD+STZ	273.7 ± 8.4a,b,d	167.3 ± 1.9a,b,dc	9.5 ± 0.09a,b,d	28.5 ± 2.4a,b,d	6.4 ± 0.19a,b,d
HFD+Lut/ZnO NPs	186.4 ± 2.9a,b,c,d	97.1 ± 1.9a,b,c,d	7.07 ± 0.06a,b,c,d	46.7 ± 1.4a,b,c,d	3.1 ± 0.14a,b,c,d
HFD+STZ+Lut/ZnO NPs	181.9 ± 2.6a,b,c,d	92.4 ± 1.6a,b,c,d	7.2 ± 0.16a,b,c,d	57.8 ± 2.5a,b,c,d	2.3 ± 0.19a,b,c,d

Triglycerides (TG) in serum (TG_s) and liver tissue (TG_t), total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C) contents. Values were expressed as Means ± SE (n = 6).

^adenote significant change versus Lut/ZnO NPs.

^bdenote significant change versus HFD.

^cdenote significant change versus HFD+STZ at p < 0.05.

^ddenote significant change versus control.